Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 3.380
+0.030 (0.90%)
Aug 4, 2026, 4:27 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.09 billion as of August 4, 2026. Its market cap has increased by 92.31% in one year.
Market Cap
1.09B
Enterprise Value
617.19M
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.38
ChartMarket Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.09B, a decrease of -80.20%. That is a compound annual growth rate of -21.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.09B | 38.89% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 2.08B |
| Circio Holding ASA | 1.95B |
| ArcticZymes Technologies ASA | 1.00B |
| Zelluna ASA | 682.40M |
| Lytix Biopharma ASA | 669.03M |
| Oncoinvent ASA | 367.23M |
| SoftOx Solutions AS | 236.24M |
| Aqua Bio Technology ASA | 74.18M |